InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Thomas Malley, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 4 open-market SEC Form 4 transactions: 1 purchase worth $575K and 3 sales worth $5.9M, reported from Jun 16, 23 to Aug 14, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 78.2K | $33.09 | $2.6M |
| Aug 13, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 50.1K | $33.32 | $1.7M |
| Aug 12, 25 | KNSAKiniksa Pharmaceuticals International, plc | SELL | 49.4K | $32.40 | $1.6M |
| Jun 16, 23 | KURAKura Oncology, Inc. | BUY | 50.0K | $11.50 | $575K |